Endospan develops and manufactures custom-made endovascular devices for aortic arch treatment, including the NEXUS Aortic Arch Stent Graft System and NEXUS DUO Aortic Arch Stent Graft.

Endospan

The NEXUS® Aortic Arch Stent Graft System by Endospan is the only CE-approved off-the-shelf branched endovascular aortic arch system. Indicated for wide range of aortic pathologies, including arch aneurysms, thoracic dissections, and PAU, NEXUS® is designed to overcome the specific challenges of the aortic arch anatomy. The NEXUS® “Dock and Lock” modular system provides stable and secured anatomical anchoring and atraumatic sealing in a wide range of anatomies.

Privately held Endospan, headquartered in Herzlia (Tel Aviv), Israel, is a pioneer in the endovascular repair of aortic arch disease including aneurysms and dissections. Endospan’s NEXUS® Aortic Arch Stent Graft System is the first endovascular off-the-shelf system with CE Mark to treat a greatly underserved group of patients diagnosed with a dilative lesion in, or near the aortic arch. While minimally invasive endovascular repair has been the standard of care for Abdominal Aortic Aneurysm (AAA), Aortic Arch Disease patients with aneurysms or dissections have not been as fortunate and have had little choice but to undergo open-chest surgery with its invasiveness and risks, lengthy hospitalization periods, and prolonged recuperation. For additional information about Endospan, visit their website at www.endospan.com.

Sequoia Capital Israel

Haisco

Endospan Ltd.

Another successful NEXUS® procedure performed to treat an aortic arch arch aneurysm by the team at the University of Chicago, including Dr. Luka Pocivavsek and Dr. Clayton Brinster, MD, FACS

Learn more about our technology: https://www.endospan.com/

#TRIOMPHEstudy #NEXUSaorta #totalarch #aorticdissection #aorticaneurysm #aorticarchrepair #aortaEd

Thank you to CARDIOMED SAC, for sharing this great NEXUS® case! 

Learn more about our technology: https://www.endospan.com/
 
CAUTION: Investigational Device - Limited by United States Law to Investigational Use.

#TRIOMPHEstudy #NEXUSaorta #totalarch #aorticdissection #aorticaneurysm #aorticarchrepair #aortaEd

It takes seamless team collaboration to execute all the details required for a PMA clinical study. This includes expert clinical support at each procedure. Thank you to Cody Barnes, Mario Cosimetti, and Al Calvino, for supporting each TRIOMPHE case with great teamwork and deep clinical expertise. Patients with aortic arch disease benefit from your hard work. 

Learn more about our technology: https://www.endospan.com/

#TRIOMPHEstudy #NEXUSaorta #totalarch #aorticdissection #aorticaneurysm #aorticarchrepair #aortaEd

Thank you to Dr. James McKinsey, Dr. Rami O. Tadros, MD, FACS, RPVI, Dr. Bert Williams, and Dr. Ismail El-Hamamsy at Icahn School of Medicine at Mount Sinai for their use of NEXUS® to treat a patient with an aortic arch dissection for the TRIOMPHE Study. 

Learn more about our technology: https://www.endospan.com/

#TRIOMPHEstudy #NEXUSaorta #totalarch #aorticdissection #aorticaneurysm #aorticarchrepair #aortaEd

Another successful NEXUS® procedure performed to treat an aortic dissection by the team at the University of Colorado Department of Surgery, including Dr. T. Brett Reece and Dr. Donald Jacobs. 

Learn more about our technology: https://www.endospan.com/

#TRIOMPHEstudy #NEXUSaorta #totalarch #aorticdissection #aorticaneurysm #aorticarchrepair #aortaEd

Thank you to the team at the UC San Diego for their recent patient enrollment in the TRIOMPHE study. The NEXUS® System was used to treat a patient with an aortic arch dissection.

Learn more about our technology: https://www.endospan.com/

#TRIOMPHEstudy #NEXUSaorta #totalarch #aorticdissection #aorticaneurysm #aorticarchrepair #aortaEd

Thank you to Dr. T. Brett Reece, Dr. Muhammad Aftab MD, FACS, FACC     Dr. Donald Jacobs, and the entire team at the University of Colorado Department of Surgery for their recent patient enrollment in the TRIOMPHE study to treat a patient with an aortic arch dissection using the NEXUS® System. 

Learn more about our technology: https://www.endospan.com/

#TRIOMPHEstudy #NEXUSaorta #totalarch #aorticdissection #aorticaneurysm #aorticarchrepair #aortaEd

Heading to CARDIOVASCULAR INNOVATIONS FOUNDATION in Denver July 18-20? Dr. Sean Crawford  from the University of Toronto will be presenting “Endovascular management of arch lesions with Dual Branch NEXUS Arch Device” on July 19 at during the 10-30-12:00 Ascending Aorta and Arch Session.

Learn more about our technology: https://www.endospan.com/

#TRIOMPHEstudy #NEXUSaorta #totalarch #aorticdissection #aorticaneurysm #aorticarchrepair #aortaEd

Thank you to Westley Ohman, MD from @Wa for his presentation of the edited live case for the NEXUS® System at #VAM2024. The case demonstrated the use of NEXUS to treat a Type 1A endoleak repair from an aortic aneurysm. 

Learn more about our technology: https://www.endospan.com/

#TRIOMPHEstudy #NEXUSaorta #totalarch #aorticdissection #aorticaneurysm #aorticarchrepair #aortaEd

Thank you to Andrew Holden the team at Auckland Regional Public Health Service for performing a recent NEXUS DUO™ procedure to treat a complex dissection. Endospan has recently expanded its portfolio in New Zealand to offer more solutions for Endovascular Aortic Arch Repair.  

Learn more about our technology: https://www.endospan.com/

#NEXUSaorta #totalarch #aorticdissection #aorticaneurysm #aorticarchrepair #aortaEd

Metric
Company Name	Endospan
Symbol
MSH ID	COM:ENDOSPAN
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices
Country	IL
Stage
Employee Count
Website	endospan.com
LinkedIn	endospan
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ENDO

COM:ENDOSPAN

Endospan

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue